Traded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 3, 2025 · Filed Oct 7, 2025
The CEO of The Vita Coco sold $215K of The Vita Coco shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$214,555
Shares × reported transaction price
65 days after results of Jul 30, 2025, 26 days before results of Oct 29, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.5% | −1.2% | −2.3% |
| 30 days | +1.7% | −0.3% | +2.0% |
| 90 days | +25.6% | +2.8% | +22.8% |
| 180 days | +19.6% | −2.1% | +21.8% |
Past results only. Not a forecast.
Traded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Jane Prior (Chief Marketing Officer) sold ~$452K of The Vita Coco Company
Scheduled in advanceTraded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.